Jump to content

Oyewale Tomori

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by ಮಲ್ನಾಡಾಚ್ ಕೊಂಕ್ಣೊ (talk | contribs) at 07:54, 22 January 2021 (Heading level fix). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Oyewale Tomori
President of the Nigerian Academy of Science 2013
Vice chancellor of Redeemer's University
In office
2004–2011
Personal details
Born (1946-02-03) 3 February 1946 (age 78)
Osun State, Nigeria
Political partyNon-Partisan

Oyewale Tomori (born 3 February 1946, Osun State, Nigeria) is a Nigerian professor of virology, educational administrator, and former vice chancellor of Redeemer's University.[1][2][3][4]

Life and career

Tomori was born in Ilesa, Osun State, Nigeria on 3 February 1946. He received a Doctor of Veterinary Medicine(DVM) from Ahmadu Bello University, Zaria as well as a Doctorate degree, Ph.D in virology from the University of Ibadan, Oyo State, Nigeria where he was appointed professor of virology in 1981, the same year he received the United States Department of Health and Human Services Public Health Service Certificate for contributions to Lassa Fever Research.[5][6][7] Three years (1984) after his appointment as a professor of virology, he was appointed the head of the Department of Virology. At the University of Ibadan Tomori's research interest focuses on viral infections including Ebola hemorrhagic fever,[8] yellow fever, Lassa fever.[9] He served as the Regional Virologist for the World Health Organization Africa Region (1994-2004) before he was appointed as the pioneer vice chancellor of Redeemer's University, Ogun State, Nigeria, a tenure that ended in 2011.[10][11] [12]

Other activities

  • Global Polio Eradication Initiative (GPEI), Member of the Polio Research Committee (PRC)
  • International Consortium on Anti-Virals (ICAV), Member of the International Steering Committee
  • Nigeria Expert Review Committee on Polio Eradication and Routine Immunization, Chairman
  • World Health Organization, Member of the Strategic Advisory Group of Experts (SAGE) on Immunization
  • Gavi Alliance, Board Member 2017

Awards and fellowships

He is a recipient of several awards and fellow of many international academic organizations. Among others are;

Selected Works

Most cited works

  • The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995 [17]
  • Yellow fever: a decade of reemergence[18]
  • Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice [19]
  • The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow [20]
  • Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses [21]

Others

  • Yellow fever: the recurring plague [22]
  • Randomised controlled trials for Ebola: practical and ethical issues [23]
  • Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo [24]
  • Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014 [25]
  • Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria [26]
  • Viral hemorrhagic fever antibodies in Nigerian populations [27]
  • Yellow fever vaccination and pregnancy: a four-year prospective study
  • Urban yellow fever epidemic in western Nigeria, 1987 [28]
  • The global virome project [29]
  • Recovery of a Lassa-related arenavirus in Zimbabwe [30]
  • Toward a common secure future: four global commissions in the wake of Ebola [31]
  • Genomic analysis of Lassa virus during an increase in cases in Nigeria in 2018 [32]
  • Impact of yellow fever on the developing world [33]
  • Monoclonal antibodies to lymphocytic choriomeningitis virus react with pathogenic arenaviruses [34]
  • Global incidence of serogroup B invasive meningococcal disease: a systematic review [35]

See also

References

  1. ^ "PROFESSOR OYEWALE TOMORI". Nigerian Young Academy. Archived from the original on October 26, 2014. Retrieved 2014-10-26.
  2. ^ Achieving Sustainable Global Capacity for Surveillance and Response to ... National Research Council. 2008. p. 98. ISBN 978-0309128186.
  3. ^ Jide Osuntokun (September 19, 2013). "Redeemer's University's 5th Convocation". The Nation Online Nigeria. Retrieved 2019-09-16.
  4. ^ Biodun Oyeleye (September 18, 2014). "Ebola: Time to reactivate surveillance for infections, says virologist". New Telegraph. Archived from the original on October 26, 2014. Retrieved 2014-10-26.
  5. ^ "Oyewale Tomori". Bulletin of the Atomic Scientists.
  6. ^ Akintayo Eribake (July 30, 2014). "Ebola: Nigeria is not out of the woods yet — Prof. Tomori". Vanguard News. Retrieved 2019-09-16.
  7. ^ "What can Nigeria's Ebola experience teach the world?". The Guardian. October 7, 2014. Retrieved 2019-09-16.
  8. ^ Kupferschmidt, Kai (2014). "Nigerian virologist delivers scathing analysis of Africa's response to Ebola". Retrieved May 30, 2020.{{cite web}}: CS1 maint: url-status (link)
  9. ^ "Tomori's appraisal of Nigerian scientists". The Punch - Nigeria's Most Widely Read Newspaper. May 23, 2013. Archived from the original on October 26, 2014. Retrieved 2014-10-26.
  10. ^ "Committee Biographies - Achieving Sustainable Global Capacity for Surveillance and Response to Emerging Diseases of Zoonotic Origin - NCBI Bookshelf".
  11. ^ "WHO - Professor Oyewale Tomori". World Health Organization. Retrieved 2019-09-16.
  12. ^ Strategic Advisory Group of Experts (SAGE) (September 1, 2010). "Immunization, Vaccines and Biologicals". WHO. Retrieved May 30, 2020.{{cite web}}: CS1 maint: url-status (link)
  13. ^ "Tomori takes over as Nigerian Academy of Science president". Daily Independent, Nigerian Newspaper. Archived from the original on October 26, 2014. Retrieved 2014-10-26.
  14. ^ "Prof. Tomori advocates for One Health Workforce". University of Nigeria. Archived from the original on October 26, 2014. Retrieved 2014-10-26.
  15. ^ "National Academy of Medicine Elects 79 New Members | National Academy of Medicine". nam.edu. October 17, 2016. Retrieved 2019-09-16.
  16. ^ "Fellows of ASTMH (FASTMH)". Retrieved 2019-09-16.
  17. ^ Khan, Ali S.; Tshioko, F. Kweteminga; Heymann, David L.; Le Guenno, Bernard; Nabeth, Pierre; Kerstiëns, Barbara; Fleerackers, Yon; Kilmarx, Peter H.; Rodier, Guenael R.; Nkuku, Okumi; Rollin, Pierre E. (1999-02-01). "The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995". The Journal of Infectious Diseases. 179 (Supplement_1): S76–S86. doi:10.1086/514306. ISSN 0022-1899. PMID 9988168.
  18. ^ Robertson, Susan E.; Hull, B. P.; Tomori, O.; Bele, O.; LeDuc, J. W.; Esteves, K. (1996). "Yellow Fever: a decade of reemergence". JAMA. 276 (14): 1157–62. doi:10.1001/jama.1996.03540140045025. ISSN 0098-7484. PMID 8827969.
  19. ^ Fisher-Hoch, S P; Tomori, O; Nasidi, A; Perez-Oronoz, G I; Fakile, Y; Hutwagner, L; McCormick, J B (1995-09-30). "Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice". BMJ. 311 (7009): 857–859. doi:10.1136/bmj.311.7009.857. ISSN 0959-8138. PMC 2550858. PMID 7580496.
  20. ^ Jentes, Emily S; Poumerol, Gilles; Gershman, Mark D; Hill, David R; Lemarchand, Johan; Lewis, Rosamund F; Staples, J Erin; Tomori, Oyewale; Wilder-Smith, Annelies; Monath, Thomas P (2011). "The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever". The Lancet Infectious Diseases. 11 (8): 622–632. doi:10.1016/S1473-3099(11)70147-5. PMID 21798462.
  21. ^ Buchmeier, Michael J.; Lewicki, Hanna A.; Tomori, Oyewale; Oldstone, Michael B.A. (1981). "Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: Generation, characterization, and cross-reactivity with other arenaviruses". Virology. 113 (1): 73–85. doi:10.1016/0042-6822(81)90137-9. PMID 6267791.
  22. ^ Tomori, Oyewale (2004). "Yellow Fever: The Recurring Plague". Critical Reviews in Clinical Laboratory Sciences. 41 (4): 391–427. doi:10.1080/10408360490497474. ISSN 1040-8363. PMID 15487593. S2CID 13559157.
  23. ^ Adebamowo, Clement; Bah-Sow, Oumou; Binka, Fred; Bruzzone, Roberto; Caplan, Arthur; Delfraissy, Jean-François; Heymann, David; Horby, Peter; Kaleebu, Pontiano; Tamfum, Jean-Jacques Muyembe; Olliaro, Piero (2014). "Randomised controlled trials for Ebola: practical and ethical issues". The Lancet. 384 (9952): 1423–1424. doi:10.1016/s0140-6736(14)61734-7. ISSN 0140-6736. PMC 4392883. PMID 25390318.
  24. ^ Bausch, Daniel G.; Borchert, Matthias; Grein, Thomas; Roth, Cathy; Swanepoel, Robert; Libande, Modeste L.; Talarmin, Antoine; Bertherat, Eric; Muyembe-Tamfum, Jean-Jacques; Tugume, Ben; Colebunders, Robert (2003). "Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo". Emerging Infectious Diseases. 9 (12): 1531–1537. doi:10.3201/eid0912.030355. ISSN 1080-6040. PMC 3034318. PMID 14720391.
  25. ^ Fasina, F O; Shittu, A; Lazarus, D; Tomori, O; Simonsen, L; Viboud, C; Chowell, G (2014-10-09). "Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014". Eurosurveillance. 19 (40): 20920. doi:10.2807/1560-7917.es2014.19.40.20920. ISSN 1560-7917. PMID 25323076.
  26. ^ Burns, C. C.; Shaw, J.; Jorba, J.; Bukbuk, D.; Adu, F.; Gumede, N.; Pate, M. A.; Abanida, E. A.; Gasasira, A.; Iber, J.; Chen, Q. (2013-02-13). "Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria". Journal of Virology. 87 (9): 4907–4922. doi:10.1128/jvi.02954-12. ISSN 0022-538X. PMID 23408630.
  27. ^ Tomori, Oyewale; Sorungbe, Akanni; Fabiyi, Akinyele; McCormick, Joseph B.; Smith, Ademola (1988-03-01). "Viral Hemorrhagic Fever Antibodies in Nigerian Populations". The American Journal of Tropical Medicine and Hygiene. 38 (2): 407–410. doi:10.4269/ajtmh.1988.38.407. ISSN 0002-9637. PMID 3128130.
  28. ^ Nasidi, A.; Monath, T.P.; DeCock, K.; Tomori, O.; Cordellier, R.; Olaleye, O.D.; Harry, T.O.; Adeniyi, J.A.; Sorungbe, A.O.; Ajose-Coker, A.O.; van Der Laan, G. (1989). "Urban yellow fever epidemic in western Nigeria, 1987". Transactions of the Royal Society of Tropical Medicine and Hygiene. 83 (3): 401–406. doi:10.1016/0035-9203(89)90518-x. ISSN 0035-9203. PMID 2617590.
  29. ^ Carroll, Dennis; Daszak, Peter; Wolfe, Nathan D.; Gao, George F.; Morel, Carlos M.; Morzaria, Subhash; Pablos-Méndez, Ariel; Tomori, Oyewale; Mazet, Jonna A. K. (2018-02-22). "The Global Virome Project". Science. 359 (6378): 872–874. doi:10.1126/science.aap7463. ISSN 0036-8075. PMID 29472471. S2CID 3543474.
  30. ^ Johnson, K. M.; Taylor, P.; Tomori, O.; Elliott, L. H. (1981-11-01). "Recovery of a Lassa-Related Arenavirus in Zimbabwe". The American Journal of Tropical Medicine and Hygiene. 30 (6): 1291–1293. doi:10.4269/ajtmh.1981.30.1291. ISSN 0002-9637. PMID 7034562.
  31. ^ Gostin, Lawrence O.; Tomori, Oyewale; Wibulpolprasert, Suwit; Jha, Ashish K.; Frenk, Julio; Moon, Suerie; Phumaphi, Joy; Piot, Peter; Stocking, Barbara; Dzau, Victor J.; Leung, Gabriel M. (2016-05-19). "Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola". PLOS Medicine. 13 (5): e1002042. doi:10.1371/journal.pmed.1002042. ISSN 1549-1676. PMID 27195954.
  32. ^ Siddle, Katherine J.; Eromon, Philomena; Barnes, Kayla G.; Mehta, Samar; Oguzie, Judith U.; Odia, Ikponmwosa; Schaffner, Stephen F.; Winnicki, Sarah M.; Shah, Rickey R.; Qu, James; Wohl, Shirlee (2018). "Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018". New England Journal of Medicine. 379 (18): 1745–1753. doi:10.1056/nejmoa1804498. ISSN 0028-4793. PMC 6181183. PMID 30332564.
  33. ^ Advances in virus research. Volume 53. Maramorosch, Karl., Murphy, Frederick A., Shatkin, Aaron J. San Diego: Academic Press. 1999. ISBN 0-12-039853-2. OCLC 646758896.{{cite book}}: CS1 maint: others (link)
  34. ^ Buchmeier, Michael J.; Lewicki, Hanna A.; Tomori, Oyewale; Johnson, Karl M. (1980). "Monoclonal antibodies to lymphocytic choriomeningitis virus react with pathogenic arenaviruses". Nature. 288 (5790): 486–487. doi:10.1038/288486a0. ISSN 0028-0836. PMID 6160402. S2CID 23522940.
  35. ^ Sridhar, Shruti; Greenwood, Brian; Head, Christopher; Plotkin, Stanley A; Sáfadi, Marco A; Saha, Samir; Taha, Muhamed-Kheir; Tomori, Oyewale; Gessner, Bradford D (2015). "Global incidence of serogroup B invasive meningococcal disease: a systematic review". The Lancet Infectious Diseases. 15 (11): 1334–1346. doi:10.1016/s1473-3099(15)00217-0. ISSN 1473-3099. PMID 26453240.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Oyewale_Tomori&oldid=1001987179"